Decision-making under risk is improved by both dopaminergic medication and subthalamic stimulation in parkinson's disease

Experimental Neurology

Volumn 254, Issue , 2014, Pages 70-77

  Boller, Jana K ^a   Barbe, Michael T ^a,c   Pauls, K Amande M ^a   Reck, Christiane ^a   Brand, Matthias ^d,e   Maier, Franziska ^a   Fink, Gereon R ^a,c   Timmermann, Lars ^a   Kalbe, Elke ^a,b  

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY OF VECHTA   (Germany)

^c FORSCHUNGSZENTRUM JÜLICH   (Germany)

^d UNIVERSITY OF DUISBURG ESSEN   (Germany)

^e ERWIN L HAHN INSTITUTE FOR MAGNETIC RESONANCE IMAGING   (Germany)

Author keywords

Cognition; Decision making; Deep brain stimulation; Dopaminergic medication; Parkinson's disease

Indexed keywords

COGNITION; DECISION-MAKING; DEEP BRAIN STIMULATION; DOPAMINERGIC MEDICATION; PARKINSON'S DISEASE;

AGED; COGNITION; DECISION MAKING; DEEP BRAIN STIMULATION; DOPAMINE AGONISTS; FEEDBACK, PSYCHOLOGICAL; FEMALE; GAMES, EXPERIMENTAL; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; RISK; RISK-TAKING; SUBTHALAMIC NUCLEUS;

EID: 84893608865     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2014.01.005     Document Type: Article

References (62)

1. Agid Y., Ruberg M., Javoy-Agid F., Hirsch E., Raisman-Vozari R., Vyas S., Faucheux B., Michel P., Kastner A., Blanchard V., Damier P., Villares J., Zhang P. Are dopaminergic neurons selectively vulnerable to Parkinson's disease?. Adv. Neurol. 1993, 60:148-164.
2. Alegret M., Junqué C., Valldeoriola F., Vendrell P., Pilleri M., Rumià J., Tolosa E. Effects of bilateral subthalamic stimulation on cognitive function in Parkinson disease. Arch. Neurol. 2001, 58:1223-1227.
3. Au W.L., Zhou J., Palmes P., Sitoh Y.-Y., Tan L.C., Rajapakse J.C. Levodopa and the feedback process on set-shifting in Parkinson's disease. Hum. Brain Mapp. 2012, 33:27-39.
4. Ballanger B., van Eimeren T., Moro E., Lozano A.M., Hamani C., Boulinguez P., Pellecchia G., Houle S., Poon Y.Y., Lang A.E., Strafella A.P. Stimulation of the subthalamic nucleus and impulsivity: release your horses. Ann. Neurol. 2009, 66:817-824.
5. Bechara A., Damasio A.R., Damasio H., Anderson S.W. Insensitivity to future consequences following damage to human prefrontal cortex. Cognition 1994, 50:7-15.
6. Bechara A., Damasio H., Tranel D., Damasio A.R. Deciding advantageously before knowing the advantageous strategy. Science 1997, 275:1293-1295.
7. Beck A.T., Steer R.A., Brown G.K. Beck depression inventory. Manual 1996, The Psychological Corporation, San Antonio. 2nd edn.
8. Brand M. Does the feedback from previous trials influence current decisions? A study on the role of feedback processing in making decisions under explicit risk conditions. J. Neuropsychol. 2008, 2:431-443.
9. Brand M., Labudda K., Kalbe E., Hilker R., Emmans D., Fuchs G., Kessler J., Markowitsch H.J. Decision-making impairments in patients with Parkinson's disease. Behav. Neurol. 2004, 15:77-85.
10. Brand M., Fujiwara E., Borsutzky S., Kalbe E., Kessler J., Markowitsch H.J. Decision-making deficits of korsakoff patients in a new gambling task with explicit rules: associations with executive functions. Neuropsychology 2005, 19:267-277.
11. Brand M., Labudda K., Markowitsch H.J. Neuropsychological correlates of decision-making in ambiguous and risky situations. Neural Netw. 2006, 19:1266-1276.
12. Brand M., Grabenhorst F., Starcke K., Vandekerckhove M.M.P., Markowitsch H.J. Role of the amygdala in decisions under ambiguity and decisions under risk: evidence from patients with Urbach-Wiethe disease. Neuropsychologia 2007, 45:1305-1317.
13. Brand M., Heinze K., Labudda K., Markowitsch H.J. The role of strategies in deciding advantageously in ambiguous and risky situations. Cogn. Process. 2008, 9:159-173.
14. Brand M., Roth-Bauer M., Driessen M., Markowitsch H.J. Executive functions and risky decision-making in patients with opiate dependence. Drug Alcohol Depend. 2008, 97:64-72.
15. Brand M., Pawlikowski M., Labudda K., Laier C., von Rothkirch N., Markowitsch H.J. Do amnesic patients with Korsakoff's syndrome use feedback when making decisions under risky conditions? An experimental investigation with the Game of Dice Task with and without feedback. Brain Cogn. 2009, 69:279-290.
16. Cavanagh J.F., Wiecki T.V., Cohen M.X., Figueroa C.M., Samanta J., Sherman S.J., Frank M.J. Subthalamic nucleus stimulation reverses mediofrontal influence over decision threshold. Nat. Neurosci. 2011, 14:1462-1467.
17. Cools R. Dopaminergic modulation of cognitive function-implications for l-DOPA treatment in Parkinson's disease. Neurosci. Biobehav. Rev. 2006, 30:1-23.
18. Cools R., Barker R.A., Sahakian B.J., Robbins T.W. l-Dopa medication remediates cognitive inflexibility, but increases impulsivity in patients with Parkinson's disease. Neuropsychologia 2003, 41:1431-1441.
19. Coulthard E.J., Bogacz R., Javed S., Mooney L.K., Murphy G., Keeley S., Whone A.L. Distinct roles of dopamine and subthalamic nucleus in learning and probabilistic decision making. Brain J. Neurol. 2012, 135:3721-3734.
20. Czernecki V., Pillon B., Houeto J.L., Pochon J.B., Levy R., Dubois B. Motivation, reward, and Parkinson's disease: influence of dopatherapy. Neuropsychologia 2002, 40:2257-2267.
21. Daniele A., Albanese A., Contarino M.F., Zinzi P., Barbier A., Gasparini F., Romito L.M., Bentivoglio A.R., Scerrati M. Cognitive and behavioural effects of chronic stimulation of the subthalamic nucleus in patients with Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 2003, 74:175-182.
22. De la Fuente-Fernández R. Frontostriatal cognitive staging in Parkinson's disease. Park. Dis. 2012, 2012:561046.
23. Euteneuer F., Schaefer F., Stuermer R., Boucsein W., Timmermann L., Barbe M.T., Ebersbach G., Otto J., Kessler J., Kalbe E. Dissociation of decision-making under ambiguity and decision-making under risk in patients with Parkinson's disease: a neuropsychological and psychophysiological study. Neuropsychologia 2009, 47:2882-2890.
24. Fimm B., Heber I.A., Coenen V.A., Fromm C., Noth J., Kronenbuerger M. Deep brain stimulation of the subthalamic nucleus improves intrinsic alertness in Parkinson's disease. Mov. Disord. 2009, 24:1613-1620.
25. Folstein M.F., Folstein S.E., McHugh P.R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 1975, 12:189-198.
26. Frank M.J. Hold your horses: a dynamic computational role for the subthalamic nucleus in decision making. Neural Netw. 2006, 19:1120-1136.
27. Frank M.J., Seeberger L.C., O'Reilly R.C. By carrot or by stick: cognitive reinforcement learning in parkinsonism. Science 2004, 306:1940-1943.
28. Frank M.J., Samanta J., Moustafa A.A., Sherman S.J. Hold your horses: impulsivity, deep brain stimulation, and medication in parkinsonism. Science 2007, 318:1309-1312.
29. Frank M.J., Scheres A., Sherman S.J. Understanding decision-making deficits in neurological conditions: insights from models of natural action selection. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2007, 362:1641-1654.
30. Funkiewiez A., Ardouin C., Cools R., Krack P., Fraix V., Batir A., Chabardes S., Benabid A.L., Robbins T.W., Pollak P. Effects of levodopa and subthalamic nucleus stimulation on cognitive and affective functioning in Parkinson's disease. Mov. Disord. 2006, 21:1656-1662.
31. Gibb W.R.G. Anatomy, pigmentation, ventral and dorsal subpopulations of the substantia nigra, and differential cell death in Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 1991, 54:388-396.
32. Gleichgerrcht E., Ibáñez A., Roca M., Torralva T., Manes F. Decision-making cognition in neurodegenerative diseases. Nat. Rev. Neurol. 2010, 6:611-623.
33. Gotham A.M., Brown R.G., Marsden C.D. Levodopa treatment may benefit or impair "frontal" function in Parkinson's disease. Lancet 1986, 2:970-971.
34. Gotham A.M., Brown R.G., Marsden C.D. "Frontal" cognitive function in patients with Parkinson's disease "on" and "off" levodopa. Brain 1988, 111(Pt 2):299-321.
35. Halpern C.H., Rick J.H., Danish S.F., Grossman M., Baltuch G.H. Cognition following bilateral deep brain stimulation surgery of the subthalamic nucleus for Parkinson's disease. Int. J. Geriatr. Psychiatry 2009, 24:443-451.
36. Herzog J., Volkmann J., Krack P., Kopper F., Potter M., Lorenz D., Steinbach M., Klebe S., Hamel W., Schrader B., Weinert D., Muller D., Mehdorn H.M., Deuschl G. Two-year follow-up of subthalamic deep brain stimulation in Parkinson's disease. Mov. Disord. 2003, 18:1332-1337.
37. Higginson C.I., Wheelock V.L., Levine D., King D.S., Pappas C.T., Sigvardt K.A. The clinical significance of neuropsychological changes following bilateral subthalamic nucleus deep brain stimulation for Parkinsons disease. J Clin Exp Neuropsychol 2009, 31:65-72.
38. Horn W. Leistungsprüfsystem. L-P-S (2. erw. Auflage) 1983, Hogrefe, Göttingen.
39. Hughes A.J., Daniel S.E., Kilford L., Lees A.J. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J. Neurol. Neurosurg. Psychiatry 1992, 55:181-184.
40. Jahanshahi M., Jenkins I.H., Brown R.G., Marsden C.D., Passingham R.E., Brooks D.J. Self-initiated versus externally triggered movements. I. An investigation using measurement of regional cerebral blood flow with PET and movement-related potentials in normal and Parkinson's disease subjects. Brain 1995, 118(Pt 4):913-933.
41. Jahanshahi M., Ardouin C.M., Brown R.G., Rothwell J.C., Obeso J., Albanese A., Rodriguez-Oroz M.C., Moro E., Benabid A.L., Pollak P., Limousin-Dowsey P. The impact of deep brain stimulation on executive function in Parkinson's disease. Brain 2000, 123(Pt 6):1142-1154.
42. Kaasinen V., Aalto S., K, N.A., Hietala J., Sonninen P., Rinne J.O. Extrastriatal dopamine D(2) receptors in Parkinson's disease: a longitudinal study. J. Neural Transm. 2003, 110:591-601.
43. Kalbe E., Calabrese P., Kohn N., Hilker R., Riedel O., Wittchen H.U., Dodel R., Otto J., Ebersbach G., Kessler J. Screening for cognitive deficits in Parkinson's disease with the Parkinson neuropsychometric dementia assessment (PANDA) instrument. Parkinsonism Relat. Disord. 2008, 14:93-101.
44. Kish S.J., Shannak K., Hornykiewicz O. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications. N. Engl. J. Med. 1988, 318:876-880.
45. Kudlicka A., Clare L., Hindle J.V. Executive functions in Parkinson's disease: systematic review and meta-analysis. Mov. Disord. 2011, 26:2305-2315.
46. Labudda K., Woermann F.G., Mertens M., Pohlmann-Eden B., Markowitsch H.J., Brand M. Neural correlates of decision making with explicit information about probabilities and incentives in elderly healthy subjects. Exp. Brain Res. 2008, 187:641-650.
47. Labudda K., Frigge K., Horstmann S., Aengenendt J., Woermann F.G., Ebner A., Markowitsch H.J., Brand M. Decision making in patients with temporal lobe epilepsy. Neuropsychologia 2009, 47:50-58.
48. Limousin P., Greene J., Pollak P., Rothwell J., Benabid A.L., Frackowiak R. Changes in cerebral activity pattern due to subthalamic nucleus or internal pallidum stimulation in Parkinson's disease. Ann. Neurol. 1997, 42:283-291.
49. Marshall D.F., Strutt A.M., Williams A.E., Simpson R.K., Jankovic J., York M.K. Alternating verbal fluency performance following bilateral subthalamic nucleus deep brain stimulation for Parkinson's disease. Eur. J. Neurol. 2012, 19:1525-1531.
50. Muslimovic D. Cognitive profile of patients with newly diagnosed Parkinson disease. Neurology 2005, 65:1239-1245.
51. Naskar S., Sood S.K., Goyal V., Dhara M. Mechanism(s) of deep brain stimulation and insights into cognitive outcomes in Parkinson's disease. Brain Res. Rev. 2010, 65:1-13.
52. Rogers R.D., Wielenberg B., Wojtecki L., Elben S., Campbell-Meiklejohn D., Schnitzler A. Deep brain stimulation of the subthalamic nucleus transiently enhances loss-chasing behaviour in patients with Parkinson's disease. Exp. Neurol. 2011, 231:181-189.
53. Rutledge R.B., Lazzaro S.C., Lau B., Myers C.E., Gluck M.A., Glimcher P.W. Dopaminergic drugs modulate learning rates and perseveration in Parkinson's patients in a dynamic foraging task. J. Neurosci. 2009, 29:15104-15114.
54. Schiebener J., Zamarian L., Delazer M., Brand M. Executive functions, categorization of probabilities, and learning from feedback: what does really matter for decision making under explicit risk conditions?. J. Clin. Exp. Neuropsychol. 2011, 33:1025-1039.
55. Schoenberg M.R., Mash K.M., Bharucha K.J., Francel P.C., Scott J.G. Deep brain stimulation parameters associated with neuropsychological changes in subthalamic nucleus stimulation for refractory Parkinson's disease. Stereotact. Funct. Neurosurg. 2008, 86:337-344.
56. Starcke K., Tuschen-Caffier B., Markowitsch H.-J., Brand M. Skin conductance responses during decisions in ambiguous and risky situations in obsessive-compulsive disorder. Cogn. Neuropsychiatry 2009, 14:199-216.
57. Strauss E., Sherman E.M.S., Spreen O. A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary 2006, Oxford University Press, New York. 3rd ed.
58. Thiel A., Hilker R., Kessler J., Habedank B., Herholz K., Heiss W.D. Activation of basal ganglia loops in idiopathic Parkinson's disease: a PET study. J. Neural Transm. 2003, 110:1289-1301.
59. Wojtecki L., Timmermann L., Jorgens S., Sudmeyer M., Maarouf M., Treuer H., Gross J., Lehrke R., Koulousakis A., Voges J., Sturm V., Schnitzler A. Frequency-dependent reciprocal modulation of verbal fluency and motor functions in subthalamic deep brain stimulation. Arch Neurol 2006, (63).
60. Zangaglia R., Pacchetti C., Pasotti C., Mancini F., Servello D., Sinforiani E., Cristina S., Sassi M., Nappi G. Deep brain stimulation and cognitive functions in Parkinson's disease: a three-year controlled study. Mov. Disord 2009, 24:1621-1628.
61. Zgaljardic D.J., Borod J.C., Foldi N.S., Mattis P. A review of the cognitive and behavioral sequelae of Parkinson's disease: relationship to frontostriatal circuitry. Cogn. Behav. Neurol. 2003, 16:193-210.
62. Zgaljardic D.J., Borod J.C., Foldi N.S., Mattis P.J., Gordon M.F., Feigin A., Eidelberg D. An examination of executive dysfunction associated with frontostriatal circuitry in Parkinson's disease. J. Clin. Exp. Neuropsychol. 2006, 28:1127-1144.